ACTA1 and Hepatic fibrosis: As expected, 8 weeks of CCl4 administration caused hepatic fibrosis in the livers of the treated mice as assessed by serum detection, Masson staining and the expression of α-SMA (smooth muscle actin) at the translational level (Fig. S1B–D).